Increased Lacrimal Fluid Level of HMGB1 in Vernal Keratoconjunctivitis.

Purpose: The aim of the present prospective study was to evaluate the lacrimal fluid concentration of HMGB1 in young patients affected by Vernal Keratoconjunctivitis (VKC) compared to a control group of healthy subjects of same age. Methods: Tear fluids was collected in a group of VKC patients and c...

Descripción completa

Detalles Bibliográficos
Publicado en:Ocular Immunology & Inflammation Vol. 27; no. 5; pp. 808 - 813
Autores principales: Caputo, Roberto, Pasti, Mattia, de Libero, Cinzia, Mori, Francesca, Barni, Simona, Danti, Gioia, Buonvicino, Daniela, Urru, Matteo, Chiarugi, Alberto, Pucci, Neri
Formato: research tables/charts Journal Article
Publicado: Taylor & Francis Ltd 2019
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Purpose: The aim of the present prospective study was to evaluate the lacrimal fluid concentration of HMGB1 in young patients affected by Vernal Keratoconjunctivitis (VKC) compared to a control group of healthy subjects of same age. Methods: Tear fluids was collected in a group of VKC patients and compared to a control group of healthy subjects. HMGB1 concentration was measured using the HMGB1 ELISA II test both in VCK and control subjects. Results: The mean concentration of HMGB1 in tear fluids of 45 VKC patients was 0,977 ± 0,72 ng/ml whereas in the control group was 0,24 ± 0,25 ng/ml and the difference was statistically significant (p = 0,000106) Conclusion: The concentration of HMGB1 in VCK patients was found to be significantly increased, suggesting a possible role of this protein in the inflammatory mechanism of VKC.